Called $GOOGL bullish on Apr 29, 2025: $GOOGL rose 112% in 9 months.
View call →GARP Investing: Great Businesses + Attractive Valuations. Deep fundamental analysis paired with tactical entry zones
Cite asCryptoQuant has tracked the directional calls on UNH by @qualitystocks on Substack since Dec 2023: not yet scored on UNH (as of Nov 19, 2026).
Other assets covered (16)
4 UNH calls on record, a thin history.
Relative view by default: fewer than 30 UNH calls or days on record.
Sentiment timeline shows relative sentiment within this analyst's history. A perma-bull showing 8 bullish : 2 bearish in a bear market sets that as their baseline. If you notice any errors, claim @substack:qualitystocks to submit corrections.
Hover the chart to read the thesis of that period · click a day to pin it
The 2 Most Important Charts to Understand Today's Market
Some charts are so simple, yet so powerful, that every investor should keep them in mind. They illustrate fundamental concepts that are easy to understand but often difficult to apply in practice. This article will be deliberately short. My goal is to make sure you walk away with a clear understanding of these essential concepts and why they are particularly relevant in today’s market. Join 22,000+ investors receiving our weekly GARP research Chart 1: the Bubble Cycle The bubble cycle is interesting because it links stock prices, investor sentiment, and overall market sentiment. It can occur in individual stocks, sectors, or even the entire market. The different stages are not necessarily easy to identify, but they become easier to recognize once we reach the “Mania Phase.” During the mania phase, you hear almost everyone (easy to find on X or Substack) talking about a particular stock. You hear phrases like “this time is different,” “valuations don’t matter given the potential market” or “to the moon.” Charts become hyperbolic. It is by no means a good time for long-term investors to enter. However, momentum investors thrive and deliver great returns. At the top, the number of IPOs increases, gains seem easy… but funds and large institutional investors begin to exit. Retail investors become increasingly involved. Then the stock price starts to fall. You hear the same so-called experts calling this dip an opportunity (as they have been doing for months or quarters). But this time, the dip keeps dipping and you read plenty of investment theses explaining why the market is wrong and why you should buy even more. That is the denial phase. Then comes a local bottom and the stock bounces back due to technical factors. The narrative follows and many bulls deploy most of their remaining capital. The “return to normal”, or dead cat bounce, completes the transfer of stock ownership from institutional to retail investors. Then begins the massive decline. People despair, lose faith in the stock and start selling. The despair phase is easy to identify: nobody talks about the stock anymore (relative to its size) and when you present a bullish thesis, people tell you: “don’t, the stock is dead.” Of course, if the stock is truly dead, it won’t bounce back. That is exactly what Terry Smith got wrong. In July, Terry Smith made a surprising shift in his investment strategy: away from quality and toward momentum. At the time, I wrote an article explaining why I believed this was a mistake and potentially a warning sign of a market top. 4 months later, the numbers speak for themselves: 🟢 13 stocks sold: +9.7% average return 🔴 12 stocks bought: +1.2% average return That’s 8.5 percentage points of outperformance for the stocks he decided to sell. Of course, four months is too short to judge a long-term strategy. But the early results are telling. Chart 2: the Gartner Hype Cycle Source: Beantin The Gartner Hype Cycle is an easy-to-understand chart that illustrates Amara’s Law: “we tend to overestimate the effect of a technology in the short run and underestimate its effect in the long run”. At first, we expect a lot from an innovation. Then reality strikes. What works in certain situations cannot necessarily be generalized overnight. The expected benefits take longer to materialize, and other elements need time to adapt. But gradually, the innovation spreads and adoption accelerates. Its benefits become increasingly visible, generating significant productivity gains and economic value until the technology eventually reaches widespread adoption and maturity. Some Examples in Today’s Market Accenture In April, the global narrative stated that Accenture’s business model was dead because of AI. Of course, its business model will change but in the short and medium term, AI requires a lot of energy to deploy, therefore IT consulting is required. Additionally, AI is also a way to improve the productivity of its workforce and therefore the will to launch projects from companies. So the market has been too fast: believing the stock was instantly dead. The result: +100% from the bottom in several months AI Infrastructure, the Semiconductor Equipments KLA Corporation Teradyne Lam Research Here are the weekly charts of three semiconductor equipment companies: Lam Research, KLA Corporation, and Teradyne. Don’t you see something familiar? Of course, I am not suggesting that the entire market is in a bubble. In fact, there is considerable weakness beneath the surface, with roughly 30% of S&P 500 stocks already in bear-market territory. However, looking at these three stocks, I believe we can clearly recognize characteristics of the mania phase, followed by a sharp correction and what looks like the denial phase. But the real question is: are we approaching a bottom or are we currently experiencing the “return to normal” phase? My main scenario is the latter. I can easily imagine these stocks rebounding in the coming weeks, driven by technical factors and renewed enthusiasm around the AI narrative. This could even coincide with a seasonal year-end rally. But will it last? I am not so sure. The problem is that valuations still rely heavily on ambitious growth expectations over the coming years. Even a slight downward revision to future revenue or earnings forecasts could significantly affect valuations, especially with long-term interest rates remaining elevated. Therefore, I believe we could see better buying opportunities further down the road. Please note, this do not change my view on AI: it is a revolution. But will it come as quickly as expected? This is where the Amara’s law is relevant. Of course, this is only my main scenario and I could be wrong. What is certain, however, is that the current risk/reward looks considerably more attractive than it did at the top, when valuations left very little room for disappointment. Conclusion These two charts remind us of something essential: the market can be right about the long-term potential of a technology while being completely wrong about its short-term impact and the valuations of the companies benefiting from it. I strongly believe AI will transform our economies and create tremendous value. I also believe that the real winners won’t probably be in the AI infrastructure, as for the 1840s railway mania . But that doesn’t mean every AI-related stock is a good investment, especially when expectations are already extremely high. The difficulty is that nobody knows exactly where we are in these cycles. We can identify patterns, assess probabilities and build scenarios, but we cannot predict the future with certainty. That is why I believe discipline, patience and valuation matter more than ever: and that is the exact purpose of the Quality Stocks Investment Framework that you can find along with a lot of content in my Quality Stocks Hub . Don’t chase a stock simply because everyone is talking about it. Don’t assume that a 40% correction automatically makes it cheap. And don’t abandon a quality business just because the market has temporarily lost interest in it. The best opportunities often appear when expectations are low not when the narrative is at its strongest.
View original →What Am I Doing With Nvidia Stock?
By now, you have probably heard the news. Jensen Huang, Nvidia’s co-founder and longtime CEO, has stepped down , following reports of extramarital affairs, including one involving a woman suspected of having ties to Chinese intelligence. His departure marks a major turning point for the company he helped build into an AI powerhouse. But as investors, the question is simple: Does this create a buying opportunity or does it fundamentally damage Nvidia’s long-term investment thesis? Let’s take a quick look at the situation, the business and its current valuation before I share what I am doing with it. Join 22,000+ investors receiving our weekly GARP research The Current Situation On November 12, Nvidia announced the resignation of its co-founder and longtime CEO, Jensen Huang , following a rapidly escalating scandal. He admitted to an extramarital affair with a businesswoman whom US authorities reportedly suspect of having ties to Chinese intelligence . Reports of a second relationship with a senior Nvidia executive added further pressure. While there is currently no confirmed evidence that company secrets were compromised, the allegations raised serious national security and corporate governance concerns, prompting Nvidia’s board to launch an independent investigation. After more than 33 years under Huang’s leadership, Nvidia now faces an unexpected transition at a critical moment for the AI industry. NVidia’s CFO, Colette Kress, has been appointed interim CEO while the board searches for a permanent replacement. The Market Reaction Investors reacted sharply, sending shares lower. Nvidia’s main competitors, AMD and Broadcom, saw their shares jump by approximately 5% , as investors bet that the leadership uncertainty could encourage customers to diversify their AI chip suppliers. Meanwhile, the reaction across the broader AI ecosystem was more negative. Nvidia-dependent companies such as CoreWeave, Nebius and Oracle came under selling pressure, reflecting concerns about potential disruptions to the AI infrastructure buildout. However, major hyperscalers such as Microsoft, Amazon and Alphabet proved more resilient , with their shares actually moving higher. This makes sense: while Nvidia’s troubles create uncertainty for the AI industry, they could also strengthen the bargaining power of its largest customers. Fundamental Analysis and Key Metrics Using the Quality Stocks Investment Framework , here is how Nvidia currently scores: 🟢 Growth: 100/100 🟢 Quality: 92/100 🟢 Valuation: 81/100 Here are some key metrics: Expected revenue growth 91% in FY27 | 68% in FY28 Net profit margin 59% 2027 PE 17x Profitability ROE of 120% | ROIC of 108% These are exceptional numbers, even for a company of Nvidia’s size. Very few businesses combine such explosive growth, outstanding profitability, and a strong balance sheet. However, these figures are based on assumptions made before the recent events. And while the fundamentals remain impressive, I see two main risks investors need to consider. The first risk is obviously the uncertainty surrounding Jensen Huang’s departure . If sensitive information was compromised, the consequences could be significant, potentially including regulatory investigations, financial penalties and reputational damage. However, I don’t believe the long-term investment thesis has necessarily changed that much. First, even if substantial financial penalties materialize, they could represent one-off costs rather than a permanent deterioration in Nvidia’s earnings power. Of course, this assumes the investigation doesn’t uncover something more serious Second, while Jensen Huang has been instrumental in Nvidia’s success, no CEO is irreplaceable. Apple continued to thrive under Tim Cook after Steve Jobs, and Nvidia has built an extraordinary ecosystem, technological expertise and competitive advantages that extend beyond one individual Finally, Nvidia’s customers were already looking to diversify their chip suppliers. AMD and Broadcom have been working hard to close the technological gap and gradually capture market share. I don’t see why this scandal would fundamentally change that dynamic In other words, the situation introduces uncertainty, particularly in the short term, but I am not convinced it significantly changes Nvidia’s long-term competitive position For me, the second risk is actually more important, and it existed long before the current controversy. Nvidia is fundamentally exposed to an investment cycle. As long as hyperscalers continue investing aggressively in AI infrastructure, demand for Nvidia’s products can remain exceptionally strong. With limited competition at the high end of the market, the company benefits from extraordinary pricing power, explosive revenue growth and exceptional margins. But cycles don’t last forever. At some point, AI infrastructure spending could normalize, customers could slow their investments, or competition could become more aggressive. And when that happens, the impact could be substantial Growth could decelerate sharply, while margins could compress at the same time. This combination can be particularly painful for highly profitable companies whose valuations reflect expectations of continued exceptional performance. We’ve seen similar dynamics across the semiconductor industry before. Periods of booming demand and limited supply can generate extraordinary profits, but those profits are not necessarily sustainable indefinitely. I extensively described this fact in these articles: here and here for example This is why I am careful not to extrapolate Nvidia’s current growth rates and margins too far into the future. So, what am I actually doing with Nvidia stock? Is the recent sell-off a buying opportunity, or is it better to stay on the sidelines? In the paid section, I will share my personal investment strategy, buy zones and what I am doing Read more
View original →Trade Alert: Why I Am Selling On Holding After 16% performance in 7 weeks?
Locking profits on Accenture, up 70%, near technical resistance while keeping a meaningful long-term position
View original →The Weekly Screener - November, 09: Halozyme, Novo Nordisk, Booking, Mercadolibre & Datadog
Welcome to “The Weekly Screener” . Every week, I merge fundamentals and technicals through the Quality Stocks Investment Framework to evaluate actionable setups, fair values and key buy execution zones (along with my personal verdict on every stock). 💡 Verdict thresholds: When relevant, I also indicate the price at which valuation alone would trigger an upgrade in my verdict, assuming the fundamental outlook remains unchanged. 🎯 Paid subscribers unlock the complete breakdown for all the stocks and can nominate tickers to be featured in next week’s edition Join 22,000+ investors receiving our weekly GARP research 📚 Browse the “Weekly Screener” archive Edition of November 02, 26. Fortinet, Visa, Evolution, Nemetschek, GE Vernova Edition of October 25, 26. MSCI, RTX, SpaceX, Rollins, Netflix Edition of October 17, 26 . Blackrock, Generac, DLocal, Boston Scientific, Elastic Edition of October 11, 26 . Vistra, Halozyme, Avnet, McCormick, Pepsico Edition of October 04, 26 . Accenture, Adyen, Equasens, Nike, Applovin Edition of September 27, 26. Rollins, Eton, Insmed, Roblox, FlatexDegiro Edition of September 20, 26. McDonald’s, Evolution, Alcon, QXO, Xylem Edition of September 13, 26 . Adobe, Celestica, Modine, Sea Ltd, Intuit Edition of September 06, 26 . Lululemon, Fair Isaac, Theon, Applovin, Palo Alto Networks Edition of August 30, 26 . Veeva, Vistra, Crowdstrike, Okta, Alibaba Edition of August 23, 26 . Walmart, Taiwan Semiconductor, Reddit, Moderna, Oracle Edition of August 16, 26 . Netflix, On Holding, The Trade Desk, Adyen & Shift4 Payments 📅 The companies featured this week The stocks for this week are: Halozyme (HALO), Novo Nordisk (NVO), Booking (BKNG), Mercadolibre (MELI) & Datadog (DDOG) Data for my analyses are sourced via MarketScreener . It is my go-to platform for global stock data . If you are looking to upgrade your research toolkit, click here (Full disclosure: this is an affiliate link, so you will be supporting this newsletter at no extra cost to you!) The Quality Stocks Investment Framework Here is a quick refresher on how the Quality Stocks Investment Framework translates fundamentals into disciplined execution because we want to find great businesses built for the decade, bought at execution targets built for right now. 🔎 FIND → 🏢 UNDERSTAND → 💰 VALUE → 🎯 EXECUTE → 🚪 EXIT To dive deeper into the complete process, read the full Investment Framework guide Stock 1: Halozyme ($HALO) 💎 Fundamental Overview 🟢 Growth 90/100 🟢 Quality 87/100 🟡 Valuation 65/100 Current price: $103 Potential TSR: 13.4% per year Fair value: $97 (base) / $81 (bear) / $134 (bull) Halozyme delivered another strong quarter in Q3 2026, with revenue growing 39% YoY to $493M, royalty revenue increasing 44% to $341M. Management also raised its full-year guidance. Despite these impressive results, investors remain focused on loss-of-exclusivity risks, a recurring concern across the pharmaceutical sector. In Halozyme’s case, the expiration of key ENHANZE patents could put pressure on future royalty streams. For example, European royalty rates on DARZALEX SC, one of the company’s largest revenue contributors, could decline following the expiration of a key patent in March 2029. To mitigate this risk, management is pursuing a strategy centered on diversifying and extending its royalty portfolio, expanding partnerships with major pharmaceutical companies, accelerating new product launches and investing in next-generation drug-delivery technologies such as Hypercon and Aerocon 🎯 Buy Zones Buy zone 1 : $80 - 🟢 Moderately attractive below $80 Buy zone 2 : $60 - 🟢 Highly attractive below $60 Buy zone 3 : $47 💡 My Take on Halozyme: 🟡 Conditional Halozyme has been one of the success stories of my Multibagger Hunting portfolio. I first initiated a position in 2024 at around $45 per share, and before the recent pullback, the stock had become a 3-bagger. However, following its strong share price appreciation, I downgraded my assessment from Moderately Attractive to Conditional in my latest portfolio update , reflecting a less compelling risk-reward profile at elevated valuations. The recent correction is therefore not entirely surprising, particularly after such a strong rally. At this stage, patience is key. I prefer to let the stock consolidate and wait for more attractive entry points before considering adding to my position Join 22,000+ investors receiving our weekly GARP research Read more
View original →The Stocks I am Watching After the Sell-Off and My Buy Zones
MSFT ~10% TSR too low at 25x PE; I'd wait for $430 support
View original →